Christopher Horan insider trades

Open-market stock purchases and sales by Christopher Horan, Chief Tech Operations Officer at Artiva Biotherapeutics, Inc, from SEC Form 4 filings since May 7, 2018.

Recent trades

DateStockTradeValue
May 19, 2026ARTV Artiva Biotherapeutics, IncSold$63.1K
Feb 15, 2026ARTV Artiva Biotherapeutics, IncBought (not open market)—
Feb 15, 2026ARTV Artiva Biotherapeutics, IncSold (not open market)$8.7K
Dec 12, 2025ARTV Artiva Biotherapeutics, IncBought (not open market)—
Dec 12, 2025ARTV Artiva Biotherapeutics, IncSold (not open market)$388K
Dec 12, 2025ARTV Artiva Biotherapeutics, IncSold (not open market)$45.7K
Dec 12, 2025ARTV Artiva Biotherapeutics, IncSold (not open market)$276K
Nov 15, 2025ARTV Artiva Biotherapeutics, IncSold (not open market)$6.2K

Companies traded

  • ARTV Artiva Biotherapeutics, Inc: 1 sale, last May 19, 2026
  • DERM Dermira, Inc: other filings, last Feb 20, 2020

Get free alerts when Christopher Horan files a new trade →